valvulopathy?thrombus
Conditions
Interventions
Online management group:N/A
Routine management group:N/A
Sponsors
the Third Xiangya Hospital of Central South University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) Chinese male or female subjects aged 18 years or older; 2) Patients who have been judged by the clinician to need warfarin treatment for at least 12 weeks; 3) Patients who are willing to learn and receive warfarin software or routine anticoagulant management; 4) Patients who can provide written informed consent, communicate well with the investigators, and complete the study in accordance with the study regulations.
Exclusion criteria
Exclusion criteria: Exclusion criteria (meeting one of them is exclusion) : 1) Patients whose medical records cannot be provided or are incomplete; 2) Patients receiving or expecting to receive other forms of therapy or other anticoagulants; 3) Patients may not be able to complete the study for other reasons or may not be considered suitable for inclusion by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of time INR value is out of target range (%OOR); | — |
Secondary
| Measure | Time frame |
|---|---|
| INR compliance rate;Percentage of time the INR value is within the target range (%TTR);Patient compliance;Accuracy of the warfarin dose /INR model;Incidence of warfarin-related adverse events; | — |
Countries
China
Contacts
Public ContactYang Guoping
Clinical Trial Center of the Third Xiangya Hospital of Central South University
Outcome results
None listed